Compare · DFTX vs HPCO
DFTX vs HPCO
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Hempacco Co. Inc. (HPCO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. DFTX focuses on Medicinal Chemicals and Botanical Products, while HPCO focuses on Medicinal Chemicals and Botanical Products .
- DFTX carries a market cap of $4.08B.
- DFTX has hit the wire 6 times in the past 4 weeks while HPCO has been quiet.
- DFTX has more recent analyst coverage (8 ratings vs 0 for HPCO).
- Company
- Definium Therapeutics Inc.
- Hempacco Co. Inc.
- Price
- -
- -
- Market cap
- $4.08B
- -
- 1M return
- -13.55%
- -
- 1Y return
- +163.41%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- News (4w)
- 6
- 0
- Recent ratings
- 8
- 0
Latest DFTX
- SEC Form SCHEDULE 13G filed by Definium Therapeutics Inc.
- Definium Therapeutics Presents Topline Phase 3 Data for DT120 ODT in Generalized Anxiety Disorder and Major Depressive Disorder at 2026 NEI Fall Congress
- Definium Therapeutics to Participate at Upcoming Investor Conferences
- Definium Therapeutics to Report Third Quarter 2026 Financial Results on November 9, 2026
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics Announces New Employee Inducement Grants
- Analyst initiated coverage on Definium Therapeutics with a new price target
- Chief Medical Officer Karlin Daniel sold $396,894 worth of shares (10,853 units at $36.57) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 792,846 units (SEC Form 4) (withholding obligation)
- Chief Executive Officer Barrow Robert sold $1,153,784 worth of shares (31,550 units at $36.57) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 2,213,090 units (SEC Form 4) (for withholding tax)
- Chief Commercial Officer Wiley Matthew T. sold $113,257 worth of shares (3,097 units at $36.57) as part of a pre-agreed trading plan, decreasing direct ownership by 0.86% to 359,036 units (SEC Form 4) (for tax liability)
Latest HPCO
- Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities
- SEC Form NT 10-Q filed by Hempacco Co. Inc.
- SEC Form DEFA14A filed by Hempacco Co. Inc.
- SEC Form DEF 14A filed by Hempacco Co. Inc.
- Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 10-K filed by Hempacco Co. Inc.
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing